129 related articles for article (PubMed ID: 7917234)
1. Evaluation of various virulence tests with low virulence vaccinia virus in mice.
Ludvíková V; Kutinová L; Simonová V; Otavová M
Biologicals; 1994 Jun; 22(2):187-90. PubMed ID: 7917234
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of a vaccine strain of vaccinia virus via inactivation of interferon viroceptor.
Dénes B; Gridley DS; Fodor N; Takátsy Z; Timiryasova TM; Fodor I
J Gene Med; 2006 Jul; 8(7):814-23. PubMed ID: 16634110
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effect of vaccinia virus in glioma model.
Timiryasova TM; Li J; Chen B; Chong D; Langridge WH; Gridley DS; Fodor I
Oncol Res; 1999; 11(3):133-44. PubMed ID: 10527073
[TBL] [Abstract][Full Text] [Related]
4. Influence of the parental virus strain on the virulence and immunogenicity of recombinant vaccinia viruses expressing HBV preS2-S protein or VZV glycoprotein I.
Kutinová L; Ludvíková V; Krystofová J; Otavová M; Simonová V; Nĕmecková S; Hainz P; Vonka V
Vaccine; 1996 Aug; 14(11):1045-52. PubMed ID: 8879101
[TBL] [Abstract][Full Text] [Related]
5. Association of vaccinia virus-expressed adenovirus E3-19K glycoprotein with class I MHC and its effects on virulence in a murine pneumonia model.
Grunhaus A; Cho S; Horwitz MS
Virology; 1994 May; 200(2):535-46. PubMed ID: 8178441
[TBL] [Abstract][Full Text] [Related]
6. Vaccinia virus recombinants encoding the truncated structural gene region of Venezuelan equine encephalitis virus (VEEV) give solid protection against peripheral challenge but only partial protection against airborne challenge with virulent VEEV.
Phillpotts RJ; Lescott TL; Jacobs SC
Acta Virol; 2000 Oct; 44(5):233-9. PubMed ID: 11252667
[TBL] [Abstract][Full Text] [Related]
7. IL-12 delivery from recombinant vaccinia virus attenuates the vector and enhances the cellular immune response against HIV-1 Env in a dose-dependent manner.
Gherardi MM; Ramirez JC; Rodríguez D; Rodríguez JR; Sano G; Zavala F; Esteban M
J Immunol; 1999 Jun; 162(11):6724-33. PubMed ID: 10352291
[TBL] [Abstract][Full Text] [Related]
8. Pathogenicity and immunogenicity in mice of vaccinia viruses mutated in the viral envelope proteins A33R and B5R.
Gurt I; Abdalrhman I; Katz E
Antiviral Res; 2006 Mar; 69(3):158-64. PubMed ID: 16406098
[TBL] [Abstract][Full Text] [Related]
9. Vaccinia virus CrmE encodes a soluble and cell surface tumor necrosis factor receptor that contributes to virus virulence.
Reading PC; Khanna A; Smith GL
Virology; 2002 Jan; 292(2):285-98. PubMed ID: 11878931
[TBL] [Abstract][Full Text] [Related]
10. Effect of 3-beta-hydroxysteroid dehydrogenase gene deletion on virulence and immunogenicity of different vaccinia viruses and their recombinants.
Sroller V; Kutinová L; Nĕmecková S; Simonová V; Vonka V
Arch Virol; 1998; 143(7):1311-20. PubMed ID: 9722876
[TBL] [Abstract][Full Text] [Related]
11. Novel vaccinia vector derived from the host range restricted and highly attenuated MVA strain of vaccinia virus.
Sutter G; Moss B
Dev Biol Stand; 1995; 84():195-200. PubMed ID: 7796954
[No Abstract] [Full Text] [Related]
12. Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge.
Wyatt LS; Earl PL; Eller LA; Moss B
Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4590-5. PubMed ID: 15070762
[TBL] [Abstract][Full Text] [Related]
13. Highly attenuated poxvirus vectors.
Tartaglia J; Cox WI; Taylor J; Perkus M; Riviere M; Meignier B; Paoletti E
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1445-7. PubMed ID: 1466978
[No Abstract] [Full Text] [Related]
14. Search for optimal parent for recombinant vaccinia virus vaccines. Study of three vaccinia virus vaccinal strains and several virus lines derived from them.
Kutinová L; Ludvíková V; Simonová V; Otavová M; Krystofová J; Hainz P; Press M; Kunke D; Vonka V
Vaccine; 1995 Apr; 13(5):487-93. PubMed ID: 7639016
[TBL] [Abstract][Full Text] [Related]
15. Pathogenicity and immunogenicity of recombinant Tiantan Vaccinia Virus with deleted C12L and A53R genes.
Dai K; Liu Y; Liu M; Xu J; Huang W; Huang X; Liu L; Wan Y; Hao Y; Shao Y
Vaccine; 2008 Sep; 26(39):5062-71. PubMed ID: 18573290
[TBL] [Abstract][Full Text] [Related]
16. Effect of virulence on immunogenicity of single and double vaccinia virus recombinants expressing differently immunogenic antigens: antibody-response inhibition induced by immunization with a mixture of recombinants differing in virulence.
Kutinová L; Ludvíková V; Marešová L; Němečková Š; Brouček J; Hainz P; Vonka V
J Gen Virol; 1999 Nov; 80 ( Pt 11)():2901-2908. PubMed ID: 10580051
[TBL] [Abstract][Full Text] [Related]
17. Infectious cDNA clone of attenuated Langat tick-borne flavivirus (strain E5) and a 3' deletion mutant constructed from it exhibit decreased neuroinvasiveness in immunodeficient mice.
Pletnev AG
Virology; 2001 Apr; 282(2):288-300. PubMed ID: 11289811
[TBL] [Abstract][Full Text] [Related]
18. The N-terminal domain of the vaccinia virus E3L-protein is required for neurovirulence, but not induction of a protective immune response.
Brandt T; Heck MC; Vijaysri S; Jentarra GM; Cameron JM; Jacobs BL
Virology; 2005 Mar; 333(2):263-70. PubMed ID: 15721360
[TBL] [Abstract][Full Text] [Related]
19. Protection induced in mice against a lethal orthopox virus by the Lister strain of vaccinia virus and modified vaccinia virus Ankara (MVA).
Abdalrhman I; Gurt I; Katz E
Vaccine; 2006 May; 24(19):4152-60. PubMed ID: 16603280
[TBL] [Abstract][Full Text] [Related]
20. Reintroduction of gene(s) into an attenuated deletion mutant of vaccinia virus strain IHD-W.
Chang PY; Pogo BG
Microb Pathog; 1993 Nov; 15(5):347-57. PubMed ID: 8015416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
